Genconn Biotech actively collaborate with renowned leading biotech companies to support the development of genomic test platform for the clinical market in Taiwan. The goal is to provide a service for clinical test or medical research. We focused on the test of mutation on specific cancer genes, trying to understand drug adaptation or drug resistance among patients, in order to assist patient to identify the most feasible target therapy or treatment approach, while continue to follow-up the progression of tumor size, drug respond and tumor recurrence rate.
In the future, we will continue to incorporate advanced test platform and technology from all over the world, with a faster and precision test to identify personalized gene and biochemistry data, and establish an effective database. We will utilize analysis and integration approach, plus cross application with healthcare policy database, to optimize the strategies from test to analysis to research to personalized medicine. We will reveal an immense potential for the biomedical technology and healthcare industry in the future.